Log In
BCIQ
Print this Print this
 

Guanylate cyclase C (GCC) (GUCY2C)

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Guanylate cyclase C (GCC) (GUCY2C)

BCIQ
Print ChartPrint this
Marketed, 1 Marketed, 1 Registration, 1 Phase III, 1 Phase III, 1 Phase II, 3 Phase II, 1 Phase I, 1 Preclinical, 1
Phase of DevelopmentPreclinicalPhase IPhase IIPhase IIIRegistrationMarketed
Autoimmune

-

1

-

1

-

-

Cancer

1

-

1

-

-

-

Diagnostic

-

-

-

-

-

1

Gastrointestinal

-

-

3

1

1

1




 Products Targeting Guanylate cyclase C (GCC) (GUCY2C)
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

10

$162,033.4M

$161,195.0M

$530.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today